Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000930413-12-001600)

Filing Details

Accession Number:: 0000930413-12-001600
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-03-16 16:29:08
Reporting Period:: 2012-03-15

Filing Date:: 2012-03-16
Accepted Time:: 2012-03-16 15:29:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
727510	Enzon Pharmaceuticals Inc	ENZN	Biological Products, (No Disgnostic Substances) (2836)	222372868

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1490283	A Richard Young	C/O Enzon Pharmaceuticals, Inc. 20 Kingsbridge Road Piscataway NJ 08854		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-03-15	2,000	$6.92	19,562	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents the sale of 2,000 shares in two separate transactions, ranging from $6.92 to $6.9212 per share, resulting in a weighted average sale price per share of $6.9211. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.